Finance

Lists
Why is ELDN up 10,17%?
Dive Deeper
ELDN:NASDAQ
Eledon Pharmaceuticals Inc
2,87 $
+10,17%
(+0,26) 1D
3,05 $
+6,32% (+0,18)
After hours
Closed: 9 նոյ, 16:00:01 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ELDN...
Open
2,64 $
High
2,92 $
Low
2,61 $
Mkt. cap
232,77 մլն
Avg. vol.
860,50 հզր
Volume
1,04 մլն
52-wk high
4,49 $
52-wk low
1,36 $
EPS
-0,96 $
Beta
0,95
Shares outstanding
81,26 մլն
No. of employees
33
Open
2,64 $
High
2,92 $
Low
2,61 $
Mkt. cap
232,77 մլն
Avg. vol.
860,50 հզր
Volume
1,04 մլն
52-wk high
4,49 $
52-wk low
1,36 $
EPS
-0,96 $
Beta
0,95
Shares outstanding
81,26 մլն
No. of employees
33
News stories
From web sources and news partners
About Eledon Pharmaceuticals Inc
CEO-
Employees33
Founded2004
HeadquartersԻրվայն, Կալիֆոռնիա, Միացյալ Նահանգներ
SectorHealth Care
Industry-
Websiteeledon.com
Analyst ratings
Based on 3 analysts giving stock ratings to ELDN in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ELDN in the last 3 months.
Highest
Current 2,87 $
10,00 $ (+248,43%)
Average
8,67 $ (+202,09%)
Lowest
8,00 $ (+178,75%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert LeBoyer
Noble Financial
Buy
Reiterated
10,00 $
+248,4%
09/23/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
8,00 $
+178,7%
09/22/2026
Unknown Analyst
Guggenheim
Buy
Maintained
8,00 $
+178,7%
08/13/2026
Seema Sheoran
Rodman & Renshaw
Buy
Initiated
12,00 $
+318,1%
07/21/2026
Vamil Divan
Guggenheim
Buy
Maintained
8,00 $
+178,7%
03/20/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
14,97 մլն
17,49 մլն
17,20 մլն
18,23 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,10 մլն
3,99 մլն
3,98 մլն
4,64 մլն
Operating expense
19,07 մլն
21,48 մլն
21,18 մլն
22,87 մլն
Total operating expenses
19,07 մլն
21,48 մլն
21,18 մլն
22,87 մլն
Operating income
-19,07 մլն
-21,48 մլն
-21,18 մլն
-22,87 մլն
Other non operating income
1,61 մլն
11,07 մլն
-17,84 մլն
-8,76 մլն
EBT including unusual items
-17,46 մլն
-10,41 մլն
-39,02 մլն
-31,63 մլն
EBT excluding unusual items
-17,46 մլն
-10,41 մլն
-39,02 մլն
-31,63 մլն
Income tax expense
-
35,00 հզր
-
-
Effective tax rate
-
-0,34%
-
-
Other operating expenses
-
-
-
-
Net income
-17,46 մլն
-10,45 մլն
-39,02 մլն
-31,63 մլն
Net profit margin
-
-
-
-
Earnings per share
-0,21
-0,10
-0,33
-0,27
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps